Verisure Q1 2026 Results

Q1 2026 performance came in strong, with ARR rising 12.2% to €3,533m, revenue up 10.3% to €1,019m, and adjusted EBIT up 19.3% to €277m, lifting margin to 27.2%. The company also generated positive free cash flow of €39m. Management reaffirmed 2026 guidance for ~10% ARR growth excluding Mexico, adjusted EBIT margin above 26%, and positive free cash flow.

Analysis

This print is less about one-quarter upside and more about evidence that the company is entering a higher-quality compounding phase: growth is still running above the guided medium-term rate, but the mix is increasingly important because margin expansion and cash conversion are now appearing together. That combination tends to re-rate multiple expansion more durably than revenue beats alone, since it reduces the odds that growth is being bought with working-capital drag or reinvestment intensity.

The second-order implication is competitive pressure on smaller peers that are still trying to buy growth. If this business can sustain >26% EBIT margins while maintaining low-teens ARR growth, it forces rivals to either defend share with heavier discounting or accept slower top-line growth, which should show up over the next 2-4 quarters in weaker net retention, longer sales cycles, and more aggressive channel incentives across the sector.

The main risk is that the market extrapolates too much from one clean quarter: the current setup likely benefits from favorable mix and timing effects, and any normalization in bookings or cash conversion could stall the bullish narrative quickly. The Mexico contribution is also a reminder that reported growth quality matters; if investors stop adjusting for that, the valuation support could compress even if headline growth remains solid.

Consensus is probably underappreciating the free-cash-flow inflection. In software-like compounding stories, FCF turning positive at the same time as margin expansion often matters more than another 1-2 points of ARR outperformance, because it creates internal funding for product, sales, and selective M&A without equity dilution. That should tighten downside on pullbacks, but it also means the stock can become crowded if investors chase the ‘quality growth + cash flow’ factor trade.

Key Decisions for Investors

• Go long the name on any 3-5% post-print pullback; use a 3-6 month horizon and target a re-rating toward higher-quality growth comps if margin/FCF durability holds.
• If you already own the stock, buy downside protection with 1-2 quarter puts rather than selling the position; the key risk is not demand collapse but a reset in growth quality or cash conversion.
• Pair trade: long this name vs. a slower-growing, cash-burning peer in the same software/services sub-sector; expect relative outperformance over the next 1-2 quarters if the market rewards margin discipline.
• For new risk, express upside via call spreads 3-6 months out instead of outright shares; the reward is continued multiple expansion, while the main risk is guidance de-risking after the initial beat fades.
• Reduce exposure only if subsequent monthly/quarterly indicators show ARR deceleration below the guided ex-Mexico growth rate for two prints in a row; that would be the earliest sign the quality-inflection thesis is peaking.